Go Deep
Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,521 | 23.1 | 5.44 | 0.00 | 4,057.76 |
Chugai Pharmaceutical Co., Ltd. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 341,584,000,000.0 | 321,747,000,000.0 | 346,301,000,000.0 | 333,176,000,000.0 |
| Net Profit | 116,331,000,000.0 | 115,418,000,000.0 | 128,410,000,000.0 | 111,213,000,000.0 |
| EPS | — | 70.1 | — | — |
Chugai Pharmaceutical Co., Ltd. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 1,257,941,000,000.0 | 1,170,611,000,000.0 | 1,111,367,000,000.0 | 1,259,726,000,000.0 | — |
| Net Profit | 434,012,000,000.0 | 387,317,000,000.0 | 325,472,000,000.0 | 374,429,000,000.0 | — |
| EPS | 263.7 | 235.4 | 197.8 | 227.6 | — |
Chugai Pharmaceutical Co., Ltd. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 2,468,595,000,000.0 | 2,208,373,000,000.0 | 1,932,547,000,000.0 | 1,869,758,000,000.0 | — |
| Total Liabilities | 442,863,000,000.0 | 306,874,000,000.0 | 306,967,000,000.0 | 445,371,000,000.0 | — |
| Total Equity | 2,025,732,000,000.0 | 1,901,499,000,000.0 | 1,625,580,000,000.0 | 1,424,387,000,000.0 | — |
Chugai Pharmaceutical Co., Ltd. Assets & Liabilities Breakdown (JPY millions)
What it owns — Dec 2025
Cash & short-term investments 39.7%Receivables 17.9%Inventory 11.2%Fixed assets (tangible) 19.4%Intangible assets 2.2%Other assets 9.5%
How it's funded — Dec 2025
Payables 5.2%Other liabilities 12.8%Shareholders' equity 82.1%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 979,696.0 | 996,345.0 | 738,982.0 | 503,107.0 |
| Receivables | 442,876.0 | 334,256.0 | 318,892.0 | 512,538.0 |
| Inventory | 276,848.0 | 240,067.0 | 273,480.0 | 292,206.0 |
| Fixed assets (tangible) | 479,481.0 | 441,554.0 | 420,701.0 | 386,651.0 |
| Intangible assets | 54,539.0 | 17,868.0 | 19,860.0 | 25,141.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 1,837.0 |
| Other assets | 235,155.0 | 178,283.0 | 160,632.0 | 148,278.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 127,247.0 | 65,353.0 | 112,468.0 | 209,835.0 |
| Other liabilities | 315,616.0 | 241,521.0 | 194,499.0 | 235,536.0 |
| Shareholders' equity | 2,025,732.0 | 1,901,499.0 | 1,625,580.0 | 1,424,387.0 |
| Net tangible assets | 1,971,193.0 | 1,883,631.0 | 1,605,720.0 | 1,399,246.0 |
Chugai Pharmaceutical Co., Ltd. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 386,280,000,000.0 | 447,600,000,000.0 | 409,925,000,000.0 | 243,582,000,000.0 | — |
| Investing Activities | -201,273,000,000.0 | -227,365,000,000.0 | -37,290,000,000.0 | -145,465,000,000.0 | — |
| Financing Activities | -307,886,000,000.0 | -141,006,000,000.0 | -139,331,000,000.0 | -145,641,000,000.0 | — |